Tailoring Treatment with Tirofiban in patients showing Resistance to aspirin and/or Resistance to clopidogrel: 3T/2R.

Trial Profile

Tailoring Treatment with Tirofiban in patients showing Resistance to aspirin and/or Resistance to clopidogrel: 3T/2R.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Mar 2012

At a glance

  • Drugs Tirofiban (Primary)
  • Indications Coronary artery disease; Coronary disorders; Embolism and thrombosis; Myocardial infarction; Myocardial reperfusion injury
  • Focus Therapeutic Use
  • Acronyms 3T/2R; TREND-AR
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 30 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 30 Jun 2009 Results were published in Circulation.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top